Compliance
RSSArticles
-
What to Do When Malpractice Allegations Become Defamation
Medical malpractice litigation can get ugly, with passionate plaintiffs and indignant clinicians or hospital administrators firing off heated accusations and insults. But where is the line where a malpractice allegation becomes defamation? What can be done when that happens?
-
Summary of HHS Guidance on Provider Relief Fund Compliance
The reporting requirements for the Provider Relief Fund should not be a surprise to healthcare organizations. “Free” money usually comes with a lot of strings attached.
-
Recommended Elements of a Compliance Program
Provider Relief Fund compliance will require an extensive and far-reaching program, experts note.
-
Provider Relief Funds Require Strict Compliance Program
Risk managers and compliance officers should act now to ensure compliance programs are consistent with the latest guidelines from the Department of Health and Human Services.
-
Ongoing Noncompliance Leads to Serious Settlement for Small Clinic
Regardless of the size of a healthcare operation, the government will administer punishment for regulatory violations, especially if those errors stem from the facility's careless oversight.
-
Right of Access Initiative Yields Major Settlements with OCR
Much confusion remains about when healthcare entities can and cannot release information under HIPAA. There are some lessons to be learned from recent enforcement actions.
-
IHI Issues Action Plan on Patient Safety
The Institute for Healthcare Improvement’s National Steering Committee for Patient Safety recently released its national action plan, aimed at helping healthcare organizations reduce preventable medical harm.
-
AAAHC Takes Pragmatic Approach in Latest Edition of Handbook
There are notable updates regarding surgical site marking, high-alert medications, and quality improvement projects.
-
Neurotechnology Takes Human Research Ethics to New Frontiers
It is possible that any IRB might someday review a study that involves making healthy people smarter, cognitively faster, and more resilient mentally. Neurotechnology, including research funded by the government, also is designed to help people with Parkinson’s disease, locked-in syndrome, mental illness, and other issues. But it could take things a step further for people with no chronic conditions. This potential raises ethical questions.
-
FDA Answers Audit Questions from Researchers, Industry
The Food and Drug Administration issued new guidance on inspections during the COVID-19 pandemic, as the agency began to resume domestic inspections in July.